Use of Medicinal Cannabis for Epilepsy in the Australian Community 2023–2024: A Cross-Sectional Survey
Abstract Background and Purpose: Epilepsy is a common indication for medicinal cannabis (MC) prescription in Australia. Despite legal MC products…
Anastasia Suraev
Cannabidiol attenuates precuneus activation during appetitive cue exposure in individuals with alcohol use disorder
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s00406-025-01983-4. Article type: Research Article Keywords: Cannabidiol, Neuroimaging, Cue…
Protocol for Cancloz: multicentre randomised, placebo-controlled, double-blind, parallel-group adaptive trial of cannabidiol for clozapine-resistant schizophrenia
Abstract Background: Although clozapine is the most effective antipsychotic for people with treatment-resistant schizophrenia (TRS), only 40% of people with…
The neurobehavioural effects of cannabidiol in alcohol use disorder: Study protocol for a double-blind, randomised, cross over, placebo-controlled trial
Abstract Current treatments for alcohol use disorders (AUD) have limited efficacy. Recently, Cannabidiol (CBD) has been examined in a multitude…
Medical cannabis use in Australia seven years after legalisation: findings from the online Cannabis as Medicine Survey 2022–2023 (CAMS-22)
Abstract Background: Cannabis was legalised for medical purposes in 2016. Uptake was initially slow, but since 2019 there has been…
Evaluating possible ‘next day’ impairment in insomnia patients administered an oral medicinal cannabis product by night: a pilot randomized controlled trial
Abstract Supplementary Information: The online version contains supplementary material available at 10.1007/s00213-024-06595-9. Article type: Research Article Keywords: cannabinoids, cognition, driving…
Neuroimaging studies of cannabidiol and potential neurobiological mechanisms relevant for alcohol use disorders: a systematic review
Abstract The underlying neurobiological mechanisms of cannabidiol’s (CBD) management of alcohol use disorder (AUD) remains elusive. Aim We conducted a…
Detection of Δ9‐tetrahydrocannabinol (THC) in oral fluid using two point‐of‐collection testing devices following oral administration of a THC and cannabidiol containing oil
Abstract Point‐of‐collection testing (POCT) devices are widely used in roadside and workplace drug testing to identify recent cannabis use by…
Differences in prescribed medicinal cannabis use by cannabinoid product composition: Findings from the cannabis as medicine survey 2020 (CAMS-20) Australia-wide study
Abstract Introduction: Prescribed medicinal cannabis (MC) is an increasingly common prescription in Australia for treating pain, anxiety, and sleep disorders.…
Driving-related behaviors, attitudes, and perceptions among Australian medical cannabis users: results from the CAMS 20 survey
Abstract Supplementary Information: The online version contains supplementary material available at 10.1186/s42238-023-00202-y. Article type: Research Article Keywords: Medical cannabis, THC,…